Sandler Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-87,000
| Closed | -$7.88M | – | 154 |
|
|
2019
Q1 | $7.88M | Buy |
+87,000
| New | +$7.88M | 0.61% | 42 |
|
|
2018
Q1 | – | Sell |
-65,000
| Closed | -$5.52M | – | 148 |
|
|
2017
Q4 | $5.52M | Buy |
+65,000
| New | +$5.52M | 0.78% | 34 |
|
|
2017
Q3 | – | Sell |
-48,800
| Closed | -$3.77M | – | 148 |
|
|
2017
Q2 | $3.77M | Sell |
48,800
-111,200
| -70% | -$8.58M | 0.41% | 64 |
|
|
2017
Q1 | $11.1M | Buy |
+160,000
| New | +$11.1M | 0.76% | 21 |
|
|
2016
Q4 | – | Sell |
-134,800
| Closed | -$8.94M | – | 171 |
|
|
2016
Q3 | $8.94M | Sell |
134,800
-70,200
| -34% | -$4.65M | 1.1% | 28 |
|
|
2016
Q2 | $11.1M | Buy |
+205,000
| New | +$11.1M | 1.46% | 20 |
|
|
2015
Q1 | – | Sell |
-130,800
| Closed | -$8.13M | – | 237 |
|
|
2014
Q4 | $8.13M | Sell |
130,800
-45,351
| -26% | -$2.82M | 0.43% | 55 |
|
|
2014
Q3 | $9.16M | Sell |
176,151
-221,049
| -56% | -$11.5M | 0.43% | 59 |
|
|
2014
Q2 | $20.4M | Buy |
+397,200
| New | +$20.4M | 0.85% | 20 |
|